Searched for
TIMOLOL MALEATE OPHTHALMIC SOLUTION USP
In 1860, German chemistry PhD Albert Niemann isolated cocaine from coca leaves; the tongue-numbness he noted led to the first local anesthesia 24 years laterA simple observation of numbness from coca leaves led to a medical revolution. Scientists isolated cocaine, revealing its power to block pa...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Dr Reddy's launches generic OTC ophthalmic solution in US marketDr Reddy's Laboratories has launched a new eye drop in the United States. This over-the-counter solution treats itchy eyes. It is an antihi...
- FDC recalls over 60,000 bottles of ophthalmic solution in USFDC Ltd is recalling over 60,000 bottles of Timolol Maleate Ophthalmic Solution, a generic glaucoma medication, in the US market. The USFDA...
- Glenmark, FDC recall products in US due to manufacturing issues: USFDAGlenmark Pharmaceuticals and FDC Ltd are recalling some products in the US market. Glenmark is recalling certain strengths of Carvedilol ta...
- Glenmark launches generic ophthalmic solution in US marketGlenmark Pharmaceuticals' subsidiary has introduced Latanoprost ophthalmic solution, a generic medication for glaucoma, in the US market. T...
- Glenmark launches generic glaucoma treatment ophthalmic solutionGlenmark Pharmaceuticals Inc., USA launched a generic version of Travatan Z, a glaucoma treatment, called Travoprost ophthalmic solution (0...
- Dr Reddy's, FDC recall products in US for manufacturing issuesDr Reddy's Laboratories and FDC Ltd issued voluntary recalls for medications in the US market due to manufacturing defects. Dr Reddy's reca...
- Suspended eye drops not intended to replace glasses, says Entod CEOMumbai-based Entod Pharmaceuticals clarified that its eye drop PresVu is not intended to replace reading glasses for presbyopia. This follo...
- DCGI suspends permission to Entod pharma's eye drop, company to challenge order in courtThe DCGI has suspended Entod Pharmaceuticals' permission to manufacture and sell eye drops claimed to reduce dependency on reading glasses ...
- Aurobindo, Glenmark, FDC recall products in US market over manufacturing issues: USFDAThe New Jersey-based Aurobindo Pharma USA Inc initiated the Class 1 recall on July 11, it said. As per the US health regulator, a Class I r...
- Dr Reddy's, Sun Pharma, Aurobindo recall products in USThe company is also recalling another lot of sapropterin dihydrochloride for the same reason, it added. The USFDA said the drug maker initi...
- Alembic, Aurobindo recall drugs in US marketAlembic Pharmaceuticals and Aurobindo Pharma are recalling products in the US due to manufacturing problems. Alembic is recalling 82,400 bo...
- Dr Reddy's Laboratories launches over-the-counter eye allergy drop in USDr Reddy's said Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2 per cent and 0.1 per cent, are indicated for the temporary relief of...
- Alembic Pharma gets USFDA nod for 2 generic productsThe product is generic version of Sanofi-Aventis US LLC's Aubagio tablets in the same strengths.
- Alembic Pharmaceuticals gets USFDA nod for ophthalmic solutionThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride ophthalmic solut...
- Aurobindo Pharma gets USFDA nod for its conjunctivitis drugAurobindo Pharma has received approval from the USFDA nod for generic Olopatadine Hydrochloride ophthalmic solution used for treatment of c...
- Lupin launches generic ophthalmic solution in US marketLupin launched generic version of Allergan Inc's Zymaxid Ophthalmic Solution in US market with 180 days of marketing exclusivity.
- FDC gets USFDA nod for antibiotic drugPharmaceutical firm FDC Ltd on Wednesday said it has received an approval from the USFDA for its antibiotic drug Ciprofloxacin Ophthalmic S...
Load More
